Literature DB >> 6217862

Extrahypothalamic vasopressin is unchanged in Parkinson's disease and Huntington's disease.

M N Rossor, S P Hunt, L L Iversen, R Bannister, J Hawthorn, V T Ang, J S Jenkins.   

Abstract

Vasopressin immunoreactivity was measured post-mortem in the locus coeruleus and substantia nigra of 16 cases of Parkinson's disease and multisystem atrophy, 10 cases of Huntington's chorea and 28 normal controls. Amounts of vasopressin did not differ significantly (P greater than 0.05) between the 3 groups. Immunohistochemistry demonstrated vasopressin within nerve terminals. These data are consistent with an extrinsic vasopressin system in the human locus coeruleus and substantia nigra.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6217862     DOI: 10.1016/0006-8993(82)90706-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

Review 1.  Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.

Authors:  A Leake; I N Ferrier
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

2.  Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.

Authors:  K Fujiyoshi; H Suga; K Okamoto; S Nakamura; M Kameyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-07       Impact factor: 10.154

3.  Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease.

Authors:  Daniel J van Wamelen; N Ahmad Aziz; Jasper J Anink; Robin van Steenhoven; Debora Angeloni; Franco Fraschini; Ralf Jockers; Raymund A C Roos; Dick F Swaab
Journal:  Sleep       Date:  2013-01-01       Impact factor: 5.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.